Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s Net Profit Dropped 35.4% in 2022

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (上海复旦张江生物医药股份有限公司) (688505.SH) reported a net profit of 137.3 million yuan in 2022, down 35.4% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, down 9.6% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 723 million yuan in total liabilities, with a liability-to-asset ratio of 24.3%.